Ketamine Topical

DRUG2 trials

Sponsors

Northwell Health, University of Oklahoma

Conditions

Cancer of Head and NeckHead and Neck CancerMucositis OralPharyngeal Mucositis

Phase 2

Efficacy of Ketamine Mouthwash in the Management of Oral and Pharyngeal Toxicity Associated With Head and Neck Chemoradiotherapy: A Phase 2, Simon 2-stage Trial

WithdrawnNCT05331131

Northwell HealthCancer of Head and Neck, Mucositis Oral, Pharyngeal Mucositis

Start: 2022-09-19End: 2025-11-14Updated: 2024-01-24

Head and Neck Cancer Patients With Oral Mucositis Treated With Ketamine Oral Rinse

Not yet recruitingNCT06660017

University of OklahomaHead and Neck Cancer

Start: 2026-09-01End: 2027-11-01Target: 62Updated: 2026-08-18

Related Papers

Efficacy of ketamine mouthwash in the management of oral and pharyngeal toxicity associated with head and neck chemoradiotherapy: protocol for a phase II, Simon’s two-stage trial

BMJ Open2023-04-011 citations